Global Anthrax Vaccine Market Outlook 2024, Forecast To 2033
11 Jul, 2024
The anthrax vaccine market size has shown steady growth in recent years, increasing from $10.74 billion in 2023 to $11.27 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. This growth in the historic period is attributed to concerns over biological warfare, military demand, outbreaks of anthrax, public health preparedness, and biodefense programs. Looking ahead, the market is expected to continue its strong growth trajectory, reaching $13.80 billion by 2028 with a CAGR of 5.2%. This forecasted growth is driven by global security challenges, emerging threats, government procurement initiatives, and pandemic preparedness efforts. Key trends in the forecast period include advancements in technology, increased accessibility in developing countries, development of next-generation vaccines, government stockpiling, and collaborative research efforts.
Major Driver In The Anthrax Vaccine Market
The rising prevalence of infectious diseases is expected to propel the growth of the anthrax vaccine market going forward. Infectious diseases, caused by pathogenic microorganisms like bacteria and viruses, spread via direct or indirect contact, leading to varying degrees of severity in symptoms. This prevalence stems from demographic shifts, urbanization, environmental changes, and evolving human behaviors. The anthrax vaccine primarily guards against anthrax, with ongoing research exploring its broader immunogenic potential. For instance, as of February 2023, up to 75% of newly identified infectious diseases and 60% of known ones originate from animals, causing significant global health impacts annually. Thus, the rising disease prevalence fuels growth in the anthrax vaccine market, projected to reach substantial sizes in 2023, 2024, and 2028.
Request A Free Sample Of The Global Anthrax Vaccine Market ReportGlobal Anthrax Vaccine Market Segmentation
The anthrax vaccine market covered in this report is segmented –
1) By Vaccine Type: Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine
2) By Application Type: Animal Use, Human Use
3) By Distribution Channel: Hospitals, Pharmacies, Other Distribution Channels
By Geography:The regions covered in the anthrax vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the anthrax vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The Anthrax Vaccine Global Market Report 2024 furnishes information about the global anthrax vaccine market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
Anthrax Vaccine Market Competitive Landscape
Merck & Co. Inc., GC Biopharma, Emergent BioSolutions Inc., Indian Immunologicals Limited, Valneva SE, PharmAthene Inc, Porton Biopharma Limited, Pfenex Inc., Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company, Inc., Elusys Therapeutics Inc., SIGA Technologies Inc., Inovio Pharmaceuticals, Botswana Vaccine Institute, JOVAC, Prokarium, Soligenix Inc., Vaxart Inc., DynPort Vaccine Company LLC, VECOL S.A
Purchase The Global Anthrax Vaccine Market Report Directly And Get A Swift DeliveryAnthrax Vaccine Market Overview
The anthrax vaccine is a medical product designed to provide immunity against anthrax, a severe infectious disease caused by Bacillus anthracis bacteria. It stimulates the immune system to produce antibodies against anthrax toxins through a series of injections, including initial doses and booster shots for long-term immunity.
Anthrax Vaccine Global Market Report 2023 provides data on the global anthrax vaccine market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The anthrax vaccine market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.